Abstract: A lens flare generation method and apparatus simulates lens flare effects through paraxial approximation-based linear approximation to generate a lens flare utilizing physical characteristics of a lens system while generating a lens flare at high speed. A non-linear effect may be added to a linear pattern-based lens flare effect to generate an actual lens flare reflecting most of physical characteristics generated from the lens system. A pre-recorded non-linear pattern may be used.

Abstract: Disclosed herein are compounds that selectively inhibit members of the PTP family of enzymes. Synthesized compounds demonstrated selective inhibition of TC-PTP. Also provided are methods of using the compounds and formulations containing the compounds. Also described is a fluorescence-tagged combinatorial library synthesis and screening method. And methods of using these compounds to effect enzyme activity both in cells and in vitro as well as method of using these compounds to treat diseases in human and animals.

Abstract: Provided is an ion sensor including a supporting substrate, a plurality of cells, a silicon substrate, a plurality of transistors, and an analog-digital conversion circuit. The plurality of cells, the plurality of transistors, and the analog-digital conversion circuit are provided above the supporting substrate. Each of the plurality of transistors has a corresponding gate provided on a first surface of the silicon substrate. The analog-digital conversion circuit is provided on the silicon substrate. The ion-sensing surface is provided on a second surface of the silicon substrate. The second surface is opposite to the first surface.

Abstract: Copper-catalyzed radiofluorination of iodonium salts, iodonium salts, and compounds obtained by copper-catalyzed radiofluorination of iodonium salts are disclosed. Diagnostic and therapeutic methods involving such compounds also are disclosed.

Abstract: Compositions, recombinant vaccines and live attenuated pathogens comprising one or more isolated nucleic acid molecules that encode an immunogen in combination with an isolated nucleic acid molecule that encodes IL-28 or a functional fragment thereof are disclosed. Methods of inducing an immune response in an individual against an immunogen, using such compositions are disclosed.

Abstract: A method to detect a biomarker in saliva wherein the biomarker is an extracellular mRNA, comprises detecting the extracellular mRNA in the cell-free saliva; transcriptome analysis of saliva comprises detecting a transcriptome pattern in the cell-free saliva; a method to detect genetic alterations in an organ or in a gene in the organ by analyzing saliva, comprises detecting a transcriptome pattern and/or the mRNA profiling of the gene in cell-free saliva; a method to diagnose an oral or systemic pathology disease or disorder in a subject, comprises: detecting profile of a biomarker associated with the pathology disease or disorder, in particular mRNA and/or protein, in cell-free saliva and/or serum; kits comprising identifier for at least one biomarker for performing at least one of the methods; and use of salivary biomarker salivary and/or serum mRNAs as biomarkers for oral and/or systemic pathology, disease or disorder.

Abstract: An isolation and detection method for viruses from large quantities of water or other aqueous media. The technology employs charged resins to isolate viral particles from liquid sources such as water, milk, juices, and homogenized food. Anionic resin beads are added to a sample liquid and suspended within the liquid. While in suspension the anionic beads complex with negatively charged virus particles of other pathogens. The complexed beads are then removed from the liquid, effecting the isolation of the virus. Detection techniques can then be performed directly on the complexed beads without resorting to additional steps to elute the virus or other pathogen from the bead. The methodology can be employed for the detection of bacteriophage in an aqueous medium where the bacteriophage serves as a surrogate for the presence of a pathogen or other contaminant, such as an enteric virus.

Abstract: Methods and diagnostic compositions for monitoring ER? breast cancer are disclosed. In some aspects, a method for detecting ER? breast cancer in a subject comprises obtaining a subject sample from a subject suffering from breast cancer; determining a level of NOHA in the subject sample; and comparing the level of NOHA obtained from the subject sample to the level of NOHA in a control sample, wherein a lower level of NOHA in the subject sample indicates presence of ER? breast cancer in the subject.

Abstract: A method and apparatus for automated comparison of 3D images, such as specific shapes in images, for example, for detecting vascular changes and aneurysm growth. The method comprises an adaptive geodesic active contour (GAC) approach which can be performed in a single pass, or across multiple iterations. The method uniquely utilizes shape to identify targets in two 3D images so that images can be compared if there is any shape feature. A method is also described for iterative parameter image construction, which beneficially removes false positives. The technology is particularly well-suited for use in comparing geometric changes of aneurysms, tumors, thromboses, inflammations.

Abstract: Methods for conducting controlled grafting-from radical polymerizations from biomolecules under conditions that are biologically compatible are described. The methods provide biomolecule-polymer conjugates with highly controlled structures and narrow polydispersities under aqueous reaction conditions and biological temperatures. Biomolecules, such as proteins and nucleotides can be conjugated to polymers with high levels of control.

Abstract: The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.

Abstract: The present invention provides compounds and methods for preventing and treating an immune disorder in a subject.

Abstract: A medical imaging and therapy device is provided that may include any of a number of features. The device may include a Histotripsy transducer, a generator and controller configured to deliver Histotripsy energy from the transducer to target tissue, and an imaging system. In some embodiments, a method of treating tissue with Histotripsy energy comprises positioning a focus of a histotripsy transducer on a target tissue, delivering histotripsy energy from the histotripsy transducer through a bone aberrator, forming a histotripsy bubble cloud on the focus, and preventing the formation of secondary histotripsy bubble clouds without implementing an aberration correction algorithm.

Abstract: Systems and methods are disclosed to determine the axial and/or lateral location of a particle using light modulated with temporal and/or spatial modulation pattern. The system, for example, may include a modulator configured to temporally modulate an intensity pattern of a line of light uniquely at each point along a lateral length of the line of light and produce an undiffracted modulated line of light, a first first-order diffracted line of light, and a second first-order diffracted line of light; and one or more optical elements configured to direct the undiffracted line of light and one of the first first-order diffracted line of light and the second first-order diffracted line of light toward at least one particle disposed at or near a sample region. The system may include a processor configured to determine an axial and/or a lateral position of the particle disposed at or near the sample region.

Abstract: In one general aspect, a vertebral attachment device can include an attachment member having a curved shape defining a concave surface, a flex structure included in the attachment member, and an anchor member coupled to the attachment member and protruding from the concave surface.

Abstract: An apparatus for preparing compound dispersoids of hydrophobic nanoparticles and surfactants, comprises a water supply pipeline, a compounding mixing pipeline and an aggregating pipeline; the compounding mixing pipeline comprises an ultrasonic dispersion instrument and a liquid storage tank connected in series into a loop, and a second plunger pump allowing unidirectional circulation of materials is arranged between the ultrasonic dispersion instrument and the liquid storage tank; the water supply pipeline is connected to the top of the ultrasonic dispersion instrument; and the aggregating pipeline is connected to a discharge end of the liquid storage tank.

Abstract: Provided is a non-surgical method of treatment of carpal tunnel syndrome by administering an effective amount of purified collagenase I and II by injection onto a transverse carpal ligament, without penetrating the transverse carpal ligament. The purified collagenase I and II are obtained from Clostridium histolyticum, and the effective amount is a dose comprising a concentration of approximately 0.29 mg of the purified collagenase I and II to one ml diluent.

Abstract: Provided are methods for site- and stereo-retentive cross-couplings with unactivated secondary boronic acids, which methods are particularly useful in building block-based approach for small molecule synthesis. Also provided is a method of forming an air-stable chiral secondary boronic acid.

Abstract: Assays that can measure the effect of proteasome inhibitors on target cells in a biological sample are provided. The assays include evaluation of the effects of proteasome inhibitors on proteasome activity in cells in a biological sample.

Abstract: An organic light emitting device is disclosed in which the emissive dopant material in its organic emissive layer is an organic phosphorescent emissive material and a neat film of the organic phosphorescent emissive material is disposed between the organic emissive layer and the anode as an electron blocking layer.